We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App

AI-Powered Portable Thermal Imaging Solution Could Complement Mammography for Breast Cancer Screening

By MedImaging International staff writers
Posted on 22 May 2024
Print article
Image: AI analyzes smartphone-based thermal images of chest for breast cancer risk-predictions (Photo courtesy of Thermaiscan Technology)
Image: AI analyzes smartphone-based thermal images of chest for breast cancer risk-predictions (Photo courtesy of Thermaiscan Technology)

Breast cancer remains a major global health concern for women, with increasing incidence rates and mortality. In many low- and middle-income countries, the challenge is exacerbated by limited affordability and access to mammography screening and diagnosis. A new study has now shown promising results for a breast cancer pre-screening solution (BCPS) that utilizes a smartphone-based thermal imaging sensor and artificial intelligence (AI), offering an effective early detection tool particularly in regions where mammography is not readily available or accessible.

In this retrospective clinical validation study, researchers at Erebouni Medical Center (Yerevan, Armenia) evaluated a BCPS based on a commercially available smartphone with a thermal imaging sensor powered by AI developed by Thermaiscan Technology (Stockholm, Sweden). The study aimed to compare the performance of the BCPS with mammography, which is the gold standard for initial breast cancer screening. Over a six-month period, the team screened 478 women using the BCPS, 45 of whom were subsequently diagnosed with breast cancer via biopsy. Each participant underwent the BCPS screening prior to following the standard mammography pathway; if malignancy was suspected from mammography, a biopsy confirmed the diagnosis and served as the definitive comparison for the BCPS AI results.

When patient-reported or clinical symptoms were considered alongside the BCPS results, the tool demonstrated a sensitivity of 89% and a specificity of 83% relative to mammography. Without accounting for these symptoms, sensitivity dropped to 60%, although specificity increased to 88.2%. The BCPS has potential applications in high-income countries as well, such as pre-screening women outside the recommended age range for breast cancer screening, or offering an alternative for those reluctant to undergo mammography due to fear, psychological barriers, financial issues, limited availability, cultural factors, or lack of awareness. Going forward, further research could explore additional applications of the BCPS, including the evaluation of pathological lymph nodes and comparisons with other breast cancer screening modalities like Point-of-Care Testing (POCT), MRI, and contrast-enhanced mammography (CEM). This could broaden the scope and efficacy of early breast cancer detection across different healthcare settings.

Related Links:
Erebouni Medical Center
Thermaiscan Technology

Print article



view channel
Image: The device creates microbubbles that temporarily disrupt the BBB, permitting the entry of immunotherapy into the brain (Photo courtesy of Northwestern)

Ultrasound Technology Breaks Blood-Brain Barrier for Glioblastoma Treatment

Despite extensive molecular studies, the outlook for patients diagnosed with the aggressive brain cancer known as glioblastoma (GBM) continues to be poor. This is partly due to the blood-brain barrier... Read more

Nuclear Medicine

view channel
Image: 68Ga-NC-BCH whole-body PET imaging rapidly targets an important gastrointestinal cancer biomarker in lesions in GI cancer patients (Photo courtesy of Qi, Guo, et al.; doi.org/10.2967/jnumed.123.267110)

New PET Radiotracer Enables Same-Day Imaging of Key Gastrointestinal Cancer Biomarker

Gastrointestinal cancers rank among the most prevalent cancers worldwide, contributing to over a quarter of all cancer cases and over one-third of cancer-related deaths annually. The initial symptoms of... Read more

General/Advanced Imaging

view channel
Image: The denoised image is less noisy and the defect is more detectable and visually clearer with DEMIST (Photo courtesy of Abhinav Jha/WUSTL)

Artificial Intelligence Tool Enhances Usability of Medical Images

Doctors use myocardial perfusion imaging (MPI) single-photon emission computed tomography (SPECT) images to evaluate blood flow to the heart muscle. To capture these images, patients are administered a... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.